MJFF in the News

With the announcement of Alan Alda Parkinson's diagnosis, Rachel Dolhun, MD,
explains Parkinson’s prevalence, risk factors and exercise to manage disease.

MJFF and Verily are using the Verily Smart Watch for the more than 800 participants in the landmark PPMI study to continuously track PD movements capturing physiological data to speed earlier diagnosis, new therapies and improve disease management.

Rachel Dolhun, MD, discusses how young-onset Parkinson’s disease can impact marriage and how there is cause for optimism with recent advances in the PD therapeutic pipeline.

Rachel Dolhun, MD, vice president of medical communications provides expert commentary on Parkinson's disease in a segment on Good Morning America.

Mark Frasier, PhD, senior vice president of research programs, comments on a recent Japanese study that examines the relationship between caffeine levels in the blood and Parkinson’s.

MJFF CEO, Todd Sherer, PhD, penned an op-ed in The Hill calling for a national plan to address the Parkinson's "pandemic." Sherer writes that as the population ages and the Parkinson's global prevalence increases, a collaborative, multi- agency plan is needed to better serve people with the disease and it's a smart investment given the financial burden the government will face.

Coverage of the Foundation's annual "A Funny Thing Happened on the Way to Cure Parkinson's" benefit gala.

STAT covers the launch of Fox Insight and the collaboration between MJFF and genetics testing company 23andMe. The story includes interviews with Foundation CEO Todd Sherer, PhD, and Anne Wojcicki, 23andMe CEO and co-founder.